Log In
BCIQ
Print this Print this
 

SYNB1020

  Manage Alerts
Collapse Summary General Information
Company Synlogic Inc.
DescriptionLive E. coli Nissle bacterium microbiome modified to assimilate ammonia
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationUrea cycle disorder (UCD)
Indication Details Treat urea cycle disorder (UCD)
Regulatory Designation U.S. - Orphan Drug ( Treat urea cycle disorder (UCD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today